nodes	percent_of_prediction	percent_of_DWPC	metapath
Dapagliflozin—CYP2A6—stomach cancer	0.362	1	CbGaD
Dapagliflozin—UGT1A9—Irinotecan—stomach cancer	0.0898	0.225	CbGbCtD
Dapagliflozin—UGT2B7—Epirubicin—stomach cancer	0.0873	0.219	CbGbCtD
Dapagliflozin—ABCB1—Mitomycin—stomach cancer	0.0568	0.142	CbGbCtD
Dapagliflozin—CYP2A6—Fluorouracil—stomach cancer	0.0419	0.105	CbGbCtD
Dapagliflozin—CYP2C9—Capecitabine—stomach cancer	0.0243	0.0609	CbGbCtD
Dapagliflozin—CYP1A2—Fluorouracil—stomach cancer	0.016	0.0401	CbGbCtD
Dapagliflozin—ABCB1—Irinotecan—stomach cancer	0.0146	0.0365	CbGbCtD
Dapagliflozin—CYP2C9—Fluorouracil—stomach cancer	0.0144	0.0361	CbGbCtD
Dapagliflozin—ABCB1—Docetaxel—stomach cancer	0.0107	0.0268	CbGbCtD
Dapagliflozin—CYP3A4—Irinotecan—stomach cancer	0.00872	0.0219	CbGbCtD
Dapagliflozin—ABCB1—Doxorubicin—stomach cancer	0.00795	0.02	CbGbCtD
Dapagliflozin—ABCB1—Methotrexate—stomach cancer	0.00771	0.0193	CbGbCtD
Dapagliflozin—CYP2D6—Doxorubicin—stomach cancer	0.00749	0.0188	CbGbCtD
Dapagliflozin—CYP3A4—Docetaxel—stomach cancer	0.00639	0.016	CbGbCtD
Dapagliflozin—CYP3A4—Doxorubicin—stomach cancer	0.00477	0.012	CbGbCtD
Dapagliflozin—SLC5A4—digestive system—stomach cancer	0.00354	0.119	CbGeAlD
Dapagliflozin—SLC5A1—epithelium—stomach cancer	0.00268	0.0898	CbGeAlD
Dapagliflozin—SLC5A2—endocrine gland—stomach cancer	0.00222	0.0745	CbGeAlD
Dapagliflozin—SLC5A1—digestive system—stomach cancer	0.00204	0.0683	CbGeAlD
Dapagliflozin—UGT2B4—endocrine gland—stomach cancer	0.00155	0.052	CbGeAlD
Dapagliflozin—UGT2B4—liver—stomach cancer	0.0014	0.0469	CbGeAlD
Dapagliflozin—UGT1A9—digestive system—stomach cancer	0.00128	0.043	CbGeAlD
Dapagliflozin—Canagliflozin—ALB—stomach cancer	0.00112	1	CrCbGaD
Dapagliflozin—UGT1A9—endocrine gland—stomach cancer	0.00106	0.0355	CbGeAlD
Dapagliflozin—UGT2B7—digestive system—stomach cancer	0.00103	0.0347	CbGeAlD
Dapagliflozin—UGT1A9—liver—stomach cancer	0.000955	0.032	CbGeAlD
Dapagliflozin—UGT2B7—endocrine gland—stomach cancer	0.000853	0.0286	CbGeAlD
Dapagliflozin—UGT2B7—liver—stomach cancer	0.000769	0.0258	CbGeAlD
Dapagliflozin—CYP1A2—hematopoietic system—stomach cancer	0.000559	0.0188	CbGeAlD
Dapagliflozin—CYP1A1—hematopoietic system—stomach cancer	0.000552	0.0185	CbGeAlD
Dapagliflozin—CYP2A6—liver—stomach cancer	0.000551	0.0185	CbGeAlD
Dapagliflozin—ABCB1—blood vessel—stomach cancer	0.000538	0.0181	CbGeAlD
Dapagliflozin—CYP2C9—hematopoietic system—stomach cancer	0.000531	0.0178	CbGeAlD
Dapagliflozin—CYP1A1—epithelium—stomach cancer	0.000504	0.0169	CbGeAlD
Dapagliflozin—Angina pectoris—Fluorouracil—stomach cancer	0.000423	0.00406	CcSEcCtD
Dapagliflozin—Phlebitis—Docetaxel—stomach cancer	0.000421	0.00404	CcSEcCtD
Dapagliflozin—Extravasation—Methotrexate—stomach cancer	0.000413	0.00396	CcSEcCtD
Dapagliflozin—Phlebitis—Capecitabine—stomach cancer	0.000408	0.00391	CcSEcCtD
Dapagliflozin—CYP3A4—hematopoietic system—stomach cancer	0.000405	0.0136	CbGeAlD
Dapagliflozin—Fungal infection—Doxorubicin—stomach cancer	0.000404	0.00388	CcSEcCtD
Dapagliflozin—Diabetes mellitus—Capecitabine—stomach cancer	0.000404	0.00387	CcSEcCtD
Dapagliflozin—Polyuria—Capecitabine—stomach cancer	0.0004	0.00384	CcSEcCtD
Dapagliflozin—Acute coronary syndrome—Irinotecan—stomach cancer	0.000399	0.00382	CcSEcCtD
Dapagliflozin—CYP2D6—hematopoietic system—stomach cancer	0.000398	0.0134	CbGeAlD
Dapagliflozin—Renal failure—Irinotecan—stomach cancer	0.000397	0.00381	CcSEcCtD
Dapagliflozin—Myocardial infarction—Irinotecan—stomach cancer	0.000396	0.0038	CcSEcCtD
Dapagliflozin—Neoplasm malignant—Epirubicin—stomach cancer	0.000395	0.00379	CcSEcCtD
Dapagliflozin—Dizziness—Mitomycin—stomach cancer	0.000393	0.00377	CcSEcCtD
Dapagliflozin—CYP1A2—digestive system—stomach cancer	0.000389	0.0131	CbGeAlD
Dapagliflozin—Infestation NOS—Fluorouracil—stomach cancer	0.000387	0.00372	CcSEcCtD
Dapagliflozin—Infestation—Fluorouracil—stomach cancer	0.000387	0.00372	CcSEcCtD
Dapagliflozin—Extravasation—Epirubicin—stomach cancer	0.000386	0.00371	CcSEcCtD
Dapagliflozin—CYP1A1—digestive system—stomach cancer	0.000384	0.0129	CbGeAlD
Dapagliflozin—Acute coronary syndrome—Fluorouracil—stomach cancer	0.000382	0.00366	CcSEcCtD
Dapagliflozin—Myocardial infarction—Fluorouracil—stomach cancer	0.00038	0.00364	CcSEcCtD
Dapagliflozin—Urinary tract infection—Fluorouracil—stomach cancer	0.000376	0.00361	CcSEcCtD
Dapagliflozin—Rash—Mitomycin—stomach cancer	0.000374	0.00359	CcSEcCtD
Dapagliflozin—Dermatitis—Mitomycin—stomach cancer	0.000374	0.00359	CcSEcCtD
Dapagliflozin—Headache—Mitomycin—stomach cancer	0.000372	0.00357	CcSEcCtD
Dapagliflozin—CYP2C9—digestive system—stomach cancer	0.000369	0.0124	CbGeAlD
Dapagliflozin—Thirst—Capecitabine—stomach cancer	0.000369	0.00354	CcSEcCtD
Dapagliflozin—Neoplasm malignant—Doxorubicin—stomach cancer	0.000365	0.0035	CcSEcCtD
Dapagliflozin—Hyponatraemia—Docetaxel—stomach cancer	0.000364	0.00349	CcSEcCtD
Dapagliflozin—Nocturia—Epirubicin—stomach cancer	0.000363	0.00349	CcSEcCtD
Dapagliflozin—Pain in extremity—Docetaxel—stomach cancer	0.000363	0.00348	CcSEcCtD
Dapagliflozin—Cerebrovascular accident—Capecitabine—stomach cancer	0.000358	0.00344	CcSEcCtD
Dapagliflozin—Extravasation—Doxorubicin—stomach cancer	0.000357	0.00343	CcSEcCtD
Dapagliflozin—Connective tissue disorder—Irinotecan—stomach cancer	0.000357	0.00342	CcSEcCtD
Dapagliflozin—Nausea—Mitomycin—stomach cancer	0.000353	0.00338	CcSEcCtD
Dapagliflozin—Hyponatraemia—Capecitabine—stomach cancer	0.000353	0.00338	CcSEcCtD
Dapagliflozin—Pain in extremity—Capecitabine—stomach cancer	0.000351	0.00337	CcSEcCtD
Dapagliflozin—Vaginal infection—Methotrexate—stomach cancer	0.00034	0.00326	CcSEcCtD
Dapagliflozin—Dehydration—Docetaxel—stomach cancer	0.000337	0.00324	CcSEcCtD
Dapagliflozin—Nocturia—Doxorubicin—stomach cancer	0.000336	0.00323	CcSEcCtD
Dapagliflozin—Orthostatic hypotension—Docetaxel—stomach cancer	0.000331	0.00318	CcSEcCtD
Dapagliflozin—Blood creatinine increased—Capecitabine—stomach cancer	0.000329	0.00316	CcSEcCtD
Dapagliflozin—Dehydration—Capecitabine—stomach cancer	0.000327	0.00313	CcSEcCtD
Dapagliflozin—Urine output increased—Methotrexate—stomach cancer	0.000326	0.00312	CcSEcCtD
Dapagliflozin—Neoplasm—Methotrexate—stomach cancer	0.000326	0.00312	CcSEcCtD
Dapagliflozin—Nasopharyngitis—Docetaxel—stomach cancer	0.000324	0.00311	CcSEcCtD
Dapagliflozin—CYP1A2—endocrine gland—stomach cancer	0.000321	0.0108	CbGeAlD
Dapagliflozin—Orthostatic hypotension—Capecitabine—stomach cancer	0.000321	0.00308	CcSEcCtD
Dapagliflozin—Vaginal infection—Epirubicin—stomach cancer	0.000318	0.00305	CcSEcCtD
Dapagliflozin—Blood urea increased—Epirubicin—stomach cancer	0.000318	0.00305	CcSEcCtD
Dapagliflozin—CYP1A1—endocrine gland—stomach cancer	0.000317	0.0106	CbGeAlD
Dapagliflozin—Nasopharyngitis—Capecitabine—stomach cancer	0.000314	0.00301	CcSEcCtD
Dapagliflozin—Back pain—Irinotecan—stomach cancer	0.000306	0.00293	CcSEcCtD
Dapagliflozin—Angina pectoris—Docetaxel—stomach cancer	0.000305	0.00293	CcSEcCtD
Dapagliflozin—CYP2C9—endocrine gland—stomach cancer	0.000305	0.0102	CbGeAlD
Dapagliflozin—Neoplasm—Epirubicin—stomach cancer	0.000305	0.00292	CcSEcCtD
Dapagliflozin—Influenza—Capecitabine—stomach cancer	0.000303	0.00291	CcSEcCtD
Dapagliflozin—Diabetes mellitus—Methotrexate—stomach cancer	0.000301	0.00288	CcSEcCtD
Dapagliflozin—Polyuria—Methotrexate—stomach cancer	0.000298	0.00286	CcSEcCtD
Dapagliflozin—Angina pectoris—Capecitabine—stomach cancer	0.000296	0.00284	CcSEcCtD
Dapagliflozin—Blood urea increased—Doxorubicin—stomach cancer	0.000294	0.00282	CcSEcCtD
Dapagliflozin—Vaginal infection—Doxorubicin—stomach cancer	0.000294	0.00282	CcSEcCtD
Dapagliflozin—CYP1A2—liver—stomach cancer	0.00029	0.00972	CbGeAlD
Dapagliflozin—ABCB1—hematopoietic system—stomach cancer	0.000286	0.00962	CbGeAlD
Dapagliflozin—CYP1A1—liver—stomach cancer	0.000286	0.00959	CbGeAlD
Dapagliflozin—Phlebitis—Epirubicin—stomach cancer	0.000284	0.00272	CcSEcCtD
Dapagliflozin—Dysuria—Capecitabine—stomach cancer	0.000284	0.00272	CcSEcCtD
Dapagliflozin—Neoplasm—Doxorubicin—stomach cancer	0.000282	0.00271	CcSEcCtD
Dapagliflozin—CYP3A4—digestive system—stomach cancer	0.000281	0.00945	CbGeAlD
Dapagliflozin—Diabetes mellitus—Epirubicin—stomach cancer	0.000281	0.0027	CcSEcCtD
Dapagliflozin—Infestation—Docetaxel—stomach cancer	0.000279	0.00268	CcSEcCtD
Dapagliflozin—Infestation NOS—Docetaxel—stomach cancer	0.000279	0.00268	CcSEcCtD
Dapagliflozin—CYP2D6—digestive system—stomach cancer	0.000277	0.0093	CbGeAlD
Dapagliflozin—Acute coronary syndrome—Docetaxel—stomach cancer	0.000276	0.00264	CcSEcCtD
Dapagliflozin—CYP2C9—liver—stomach cancer	0.000275	0.00923	CbGeAlD
Dapagliflozin—Renal failure—Docetaxel—stomach cancer	0.000275	0.00264	CcSEcCtD
Dapagliflozin—Myocardial infarction—Docetaxel—stomach cancer	0.000274	0.00263	CcSEcCtD
Dapagliflozin—Hypertension—Irinotecan—stomach cancer	0.000273	0.00262	CcSEcCtD
Dapagliflozin—Infestation—Capecitabine—stomach cancer	0.000271	0.0026	CcSEcCtD
Dapagliflozin—Infestation NOS—Capecitabine—stomach cancer	0.000271	0.0026	CcSEcCtD
Dapagliflozin—Acute coronary syndrome—Capecitabine—stomach cancer	0.000267	0.00256	CcSEcCtD
Dapagliflozin—Cerebrovascular accident—Methotrexate—stomach cancer	0.000267	0.00256	CcSEcCtD
Dapagliflozin—Renal failure—Capecitabine—stomach cancer	0.000266	0.00255	CcSEcCtD
Dapagliflozin—Discomfort—Irinotecan—stomach cancer	0.000266	0.00255	CcSEcCtD
Dapagliflozin—Myocardial infarction—Capecitabine—stomach cancer	0.000265	0.00255	CcSEcCtD
Dapagliflozin—Urinary tract infection—Capecitabine—stomach cancer	0.000263	0.00252	CcSEcCtD
Dapagliflozin—Phlebitis—Doxorubicin—stomach cancer	0.000263	0.00252	CcSEcCtD
Dapagliflozin—ABCB1—epithelium—stomach cancer	0.000262	0.00879	CbGeAlD
Dapagliflozin—Diabetes mellitus—Doxorubicin—stomach cancer	0.00026	0.0025	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Irinotecan—stomach cancer	0.000258	0.00247	CcSEcCtD
Dapagliflozin—Oedema—Irinotecan—stomach cancer	0.000258	0.00247	CcSEcCtD
Dapagliflozin—Infection—Irinotecan—stomach cancer	0.000256	0.00246	CcSEcCtD
Dapagliflozin—Discomfort—Fluorouracil—stomach cancer	0.000255	0.00244	CcSEcCtD
Dapagliflozin—Hypoglycaemia—Epirubicin—stomach cancer	0.000251	0.00241	CcSEcCtD
Dapagliflozin—Cerebrovascular accident—Epirubicin—stomach cancer	0.00025	0.0024	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Irinotecan—stomach cancer	0.000249	0.00239	CcSEcCtD
Dapagliflozin—Urinary tract disorder—Docetaxel—stomach cancer	0.000248	0.00238	CcSEcCtD
Dapagliflozin—Oedema—Fluorouracil—stomach cancer	0.000247	0.00237	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Fluorouracil—stomach cancer	0.000247	0.00237	CcSEcCtD
Dapagliflozin—Connective tissue disorder—Docetaxel—stomach cancer	0.000247	0.00237	CcSEcCtD
Dapagliflozin—Urethral disorder—Docetaxel—stomach cancer	0.000246	0.00236	CcSEcCtD
Dapagliflozin—Hyponatraemia—Epirubicin—stomach cancer	0.000246	0.00236	CcSEcCtD
Dapagliflozin—Infection—Fluorouracil—stomach cancer	0.000245	0.00235	CcSEcCtD
Dapagliflozin—Pain in extremity—Epirubicin—stomach cancer	0.000245	0.00235	CcSEcCtD
Dapagliflozin—Hypotension—Irinotecan—stomach cancer	0.000241	0.00231	CcSEcCtD
Dapagliflozin—Urinary tract disorder—Capecitabine—stomach cancer	0.00024	0.0023	CcSEcCtD
Dapagliflozin—Connective tissue disorder—Capecitabine—stomach cancer	0.000239	0.00229	CcSEcCtD
Dapagliflozin—Urethral disorder—Capecitabine—stomach cancer	0.000238	0.00229	CcSEcCtD
Dapagliflozin—ABCB1—pancreas—stomach cancer	0.000233	0.00783	CbGeAlD
Dapagliflozin—CYP3A4—endocrine gland—stomach cancer	0.000233	0.00781	CbGeAlD
Dapagliflozin—Hypoglycaemia—Doxorubicin—stomach cancer	0.000232	0.00223	CcSEcCtD
Dapagliflozin—Cerebrovascular accident—Doxorubicin—stomach cancer	0.000231	0.00222	CcSEcCtD
Dapagliflozin—Hypotension—Fluorouracil—stomach cancer	0.000231	0.00221	CcSEcCtD
Dapagliflozin—Blood creatinine increased—Epirubicin—stomach cancer	0.000229	0.0022	CcSEcCtD
Dapagliflozin—CYP2D6—endocrine gland—stomach cancer	0.000229	0.00768	CbGeAlD
Dapagliflozin—Dehydration—Epirubicin—stomach cancer	0.000228	0.00218	CcSEcCtD
Dapagliflozin—Hyponatraemia—Doxorubicin—stomach cancer	0.000227	0.00218	CcSEcCtD
Dapagliflozin—Pain in extremity—Doxorubicin—stomach cancer	0.000226	0.00217	CcSEcCtD
Dapagliflozin—Orthostatic hypotension—Epirubicin—stomach cancer	0.000223	0.00214	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Irinotecan—stomach cancer	0.000223	0.00214	CcSEcCtD
Dapagliflozin—Constipation—Irinotecan—stomach cancer	0.000221	0.00212	CcSEcCtD
Dapagliflozin—CYP1A1—lymph node—stomach cancer	0.000219	0.00735	CbGeAlD
Dapagliflozin—Nasopharyngitis—Epirubicin—stomach cancer	0.000219	0.0021	CcSEcCtD
Dapagliflozin—Malnutrition—Docetaxel—stomach cancer	0.000218	0.0021	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000213	0.00205	CcSEcCtD
Dapagliflozin—Blood creatinine increased—Doxorubicin—stomach cancer	0.000212	0.00203	CcSEcCtD
Dapagliflozin—Malnutrition—Capecitabine—stomach cancer	0.000211	0.00203	CcSEcCtD
Dapagliflozin—Influenza—Epirubicin—stomach cancer	0.000211	0.00203	CcSEcCtD
Dapagliflozin—Back pain—Docetaxel—stomach cancer	0.000211	0.00203	CcSEcCtD
Dapagliflozin—Dysuria—Methotrexate—stomach cancer	0.000211	0.00203	CcSEcCtD
Dapagliflozin—Dehydration—Doxorubicin—stomach cancer	0.000211	0.00202	CcSEcCtD
Dapagliflozin—CYP3A4—liver—stomach cancer	0.00021	0.00704	CbGeAlD
Dapagliflozin—Orthostatic hypotension—Doxorubicin—stomach cancer	0.000207	0.00198	CcSEcCtD
Dapagliflozin—CYP2D6—liver—stomach cancer	0.000206	0.00693	CbGeAlD
Dapagliflozin—Angina pectoris—Epirubicin—stomach cancer	0.000206	0.00198	CcSEcCtD
Dapagliflozin—Back pain—Capecitabine—stomach cancer	0.000205	0.00196	CcSEcCtD
Dapagliflozin—Body temperature increased—Irinotecan—stomach cancer	0.000204	0.00196	CcSEcCtD
Dapagliflozin—Nasopharyngitis—Doxorubicin—stomach cancer	0.000202	0.00194	CcSEcCtD
Dapagliflozin—ABCB1—lymphoid tissue—stomach cancer	0.000202	0.00677	CbGeAlD
Dapagliflozin—Infestation NOS—Methotrexate—stomach cancer	0.000201	0.00193	CcSEcCtD
Dapagliflozin—Infestation—Methotrexate—stomach cancer	0.000201	0.00193	CcSEcCtD
Dapagliflozin—ABCB1—digestive system—stomach cancer	0.000199	0.00669	CbGeAlD
Dapagliflozin—Renal failure—Methotrexate—stomach cancer	0.000198	0.0019	CcSEcCtD
Dapagliflozin—Dysuria—Epirubicin—stomach cancer	0.000198	0.0019	CcSEcCtD
Dapagliflozin—Urticaria—Fluorouracil—stomach cancer	0.000196	0.00188	CcSEcCtD
Dapagliflozin—Influenza—Doxorubicin—stomach cancer	0.000196	0.00188	CcSEcCtD
Dapagliflozin—Pollakiuria—Epirubicin—stomach cancer	0.000195	0.00187	CcSEcCtD
Dapagliflozin—Body temperature increased—Fluorouracil—stomach cancer	0.000195	0.00187	CcSEcCtD
Dapagliflozin—Angina pectoris—Doxorubicin—stomach cancer	0.000191	0.00183	CcSEcCtD
Dapagliflozin—Hypersensitivity—Irinotecan—stomach cancer	0.00019	0.00182	CcSEcCtD
Dapagliflozin—Hypertension—Docetaxel—stomach cancer	0.000189	0.00181	CcSEcCtD
Dapagliflozin—Infestation—Epirubicin—stomach cancer	0.000189	0.00181	CcSEcCtD
Dapagliflozin—Infestation NOS—Epirubicin—stomach cancer	0.000189	0.00181	CcSEcCtD
Dapagliflozin—Renal failure—Epirubicin—stomach cancer	0.000185	0.00178	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000185	0.00177	CcSEcCtD
Dapagliflozin—ABCB1—bone marrow—stomach cancer	0.000184	0.00616	CbGeAlD
Dapagliflozin—Urinary tract infection—Epirubicin—stomach cancer	0.000183	0.00176	CcSEcCtD
Dapagliflozin—Dysuria—Doxorubicin—stomach cancer	0.000183	0.00176	CcSEcCtD
Dapagliflozin—Hypertension—Capecitabine—stomach cancer	0.000183	0.00175	CcSEcCtD
Dapagliflozin—Hypersensitivity—Fluorouracil—stomach cancer	0.000182	0.00175	CcSEcCtD
Dapagliflozin—Pollakiuria—Doxorubicin—stomach cancer	0.000181	0.00173	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000179	0.00172	CcSEcCtD
Dapagliflozin—Urinary tract disorder—Methotrexate—stomach cancer	0.000179	0.00171	CcSEcCtD
Dapagliflozin—Oedema—Docetaxel—stomach cancer	0.000178	0.00171	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Docetaxel—stomach cancer	0.000178	0.00171	CcSEcCtD
Dapagliflozin—Discomfort—Capecitabine—stomach cancer	0.000178	0.00171	CcSEcCtD
Dapagliflozin—Urethral disorder—Methotrexate—stomach cancer	0.000177	0.0017	CcSEcCtD
Dapagliflozin—Infection—Docetaxel—stomach cancer	0.000177	0.0017	CcSEcCtD
Dapagliflozin—Infestation NOS—Doxorubicin—stomach cancer	0.000174	0.00167	CcSEcCtD
Dapagliflozin—Infestation—Doxorubicin—stomach cancer	0.000174	0.00167	CcSEcCtD
Dapagliflozin—Skin disorder—Docetaxel—stomach cancer	0.000173	0.00166	CcSEcCtD
Dapagliflozin—Oedema—Capecitabine—stomach cancer	0.000173	0.00166	CcSEcCtD
Dapagliflozin—Renal failure—Doxorubicin—stomach cancer	0.000171	0.00165	CcSEcCtD
Dapagliflozin—Infection—Capecitabine—stomach cancer	0.000171	0.00165	CcSEcCtD
Dapagliflozin—Dizziness—Irinotecan—stomach cancer	0.000171	0.00164	CcSEcCtD
Dapagliflozin—Urinary tract infection—Doxorubicin—stomach cancer	0.00017	0.00163	CcSEcCtD
Dapagliflozin—Skin disorder—Capecitabine—stomach cancer	0.000168	0.00161	CcSEcCtD
Dapagliflozin—Urinary tract disorder—Epirubicin—stomach cancer	0.000167	0.0016	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Capecitabine—stomach cancer	0.000167	0.0016	CcSEcCtD
Dapagliflozin—Hypotension—Docetaxel—stomach cancer	0.000167	0.0016	CcSEcCtD
Dapagliflozin—Connective tissue disorder—Epirubicin—stomach cancer	0.000166	0.0016	CcSEcCtD
Dapagliflozin—Urethral disorder—Epirubicin—stomach cancer	0.000166	0.00159	CcSEcCtD
Dapagliflozin—ABCB1—endocrine gland—stomach cancer	0.000165	0.00553	CbGeAlD
Dapagliflozin—Dizziness—Fluorouracil—stomach cancer	0.000163	0.00157	CcSEcCtD
Dapagliflozin—Rash—Irinotecan—stomach cancer	0.000163	0.00156	CcSEcCtD
Dapagliflozin—Dermatitis—Irinotecan—stomach cancer	0.000162	0.00156	CcSEcCtD
Dapagliflozin—Headache—Irinotecan—stomach cancer	0.000162	0.00155	CcSEcCtD
Dapagliflozin—Hypotension—Capecitabine—stomach cancer	0.000161	0.00155	CcSEcCtD
Dapagliflozin—Malnutrition—Methotrexate—stomach cancer	0.000157	0.00151	CcSEcCtD
Dapagliflozin—Rash—Fluorouracil—stomach cancer	0.000156	0.00149	CcSEcCtD
Dapagliflozin—Dermatitis—Fluorouracil—stomach cancer	0.000156	0.00149	CcSEcCtD
Dapagliflozin—Headache—Fluorouracil—stomach cancer	0.000155	0.00148	CcSEcCtD
Dapagliflozin—Urinary tract disorder—Doxorubicin—stomach cancer	0.000155	0.00148	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000154	0.00148	CcSEcCtD
Dapagliflozin—Connective tissue disorder—Doxorubicin—stomach cancer	0.000154	0.00148	CcSEcCtD
Dapagliflozin—Urethral disorder—Doxorubicin—stomach cancer	0.000153	0.00147	CcSEcCtD
Dapagliflozin—Nausea—Irinotecan—stomach cancer	0.000153	0.00147	CcSEcCtD
Dapagliflozin—Constipation—Docetaxel—stomach cancer	0.000152	0.00146	CcSEcCtD
Dapagliflozin—Back pain—Methotrexate—stomach cancer	0.000152	0.00146	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000149	0.00143	CcSEcCtD
Dapagliflozin—ABCB1—liver—stomach cancer	0.000148	0.00498	CbGeAlD
Dapagliflozin—Constipation—Capecitabine—stomach cancer	0.000148	0.00142	CcSEcCtD
Dapagliflozin—Malnutrition—Epirubicin—stomach cancer	0.000147	0.00141	CcSEcCtD
Dapagliflozin—Nausea—Fluorouracil—stomach cancer	0.000147	0.00141	CcSEcCtD
Dapagliflozin—Back pain—Epirubicin—stomach cancer	0.000143	0.00137	CcSEcCtD
Dapagliflozin—Body temperature increased—Docetaxel—stomach cancer	0.000141	0.00135	CcSEcCtD
Dapagliflozin—Urticaria—Capecitabine—stomach cancer	0.000137	0.00132	CcSEcCtD
Dapagliflozin—Body temperature increased—Capecitabine—stomach cancer	0.000136	0.00131	CcSEcCtD
Dapagliflozin—Malnutrition—Doxorubicin—stomach cancer	0.000136	0.00131	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000133	0.00128	CcSEcCtD
Dapagliflozin—Discomfort—Methotrexate—stomach cancer	0.000132	0.00127	CcSEcCtD
Dapagliflozin—Back pain—Doxorubicin—stomach cancer	0.000132	0.00127	CcSEcCtD
Dapagliflozin—Hypersensitivity—Docetaxel—stomach cancer	0.000131	0.00126	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Methotrexate—stomach cancer	0.000128	0.00123	CcSEcCtD
Dapagliflozin—Infection—Methotrexate—stomach cancer	0.000128	0.00122	CcSEcCtD
Dapagliflozin—Hypertension—Epirubicin—stomach cancer	0.000127	0.00122	CcSEcCtD
Dapagliflozin—Hypersensitivity—Capecitabine—stomach cancer	0.000127	0.00122	CcSEcCtD
Dapagliflozin—Skin disorder—Methotrexate—stomach cancer	0.000125	0.0012	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000125	0.0012	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Methotrexate—stomach cancer	0.000124	0.00119	CcSEcCtD
Dapagliflozin—Discomfort—Epirubicin—stomach cancer	0.000124	0.00119	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Epirubicin—stomach cancer	0.00012	0.00115	CcSEcCtD
Dapagliflozin—Oedema—Epirubicin—stomach cancer	0.00012	0.00115	CcSEcCtD
Dapagliflozin—Hypotension—Methotrexate—stomach cancer	0.00012	0.00115	CcSEcCtD
Dapagliflozin—Infection—Epirubicin—stomach cancer	0.000119	0.00115	CcSEcCtD
Dapagliflozin—Dizziness—Docetaxel—stomach cancer	0.000118	0.00113	CcSEcCtD
Dapagliflozin—Hypertension—Doxorubicin—stomach cancer	0.000118	0.00113	CcSEcCtD
Dapagliflozin—Skin disorder—Epirubicin—stomach cancer	0.000117	0.00112	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Epirubicin—stomach cancer	0.000116	0.00112	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000115	0.00111	CcSEcCtD
Dapagliflozin—Discomfort—Doxorubicin—stomach cancer	0.000115	0.0011	CcSEcCtD
Dapagliflozin—Dizziness—Capecitabine—stomach cancer	0.000114	0.0011	CcSEcCtD
Dapagliflozin—ABCB1—lymph node—stomach cancer	0.000114	0.00382	CbGeAlD
Dapagliflozin—Rash—Docetaxel—stomach cancer	0.000112	0.00108	CcSEcCtD
Dapagliflozin—Hypotension—Epirubicin—stomach cancer	0.000112	0.00108	CcSEcCtD
Dapagliflozin—Dermatitis—Docetaxel—stomach cancer	0.000112	0.00108	CcSEcCtD
Dapagliflozin—Headache—Docetaxel—stomach cancer	0.000112	0.00107	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Doxorubicin—stomach cancer	0.000111	0.00107	CcSEcCtD
Dapagliflozin—Oedema—Doxorubicin—stomach cancer	0.000111	0.00107	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000111	0.00106	CcSEcCtD
Dapagliflozin—Infection—Doxorubicin—stomach cancer	0.000111	0.00106	CcSEcCtD
Dapagliflozin—Rash—Capecitabine—stomach cancer	0.000109	0.00104	CcSEcCtD
Dapagliflozin—Dermatitis—Capecitabine—stomach cancer	0.000109	0.00104	CcSEcCtD
Dapagliflozin—Headache—Capecitabine—stomach cancer	0.000108	0.00104	CcSEcCtD
Dapagliflozin—Skin disorder—Doxorubicin—stomach cancer	0.000108	0.00104	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Doxorubicin—stomach cancer	0.000108	0.00103	CcSEcCtD
Dapagliflozin—Nausea—Docetaxel—stomach cancer	0.000106	0.00102	CcSEcCtD
Dapagliflozin—Hypotension—Doxorubicin—stomach cancer	0.000104	0.000998	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000104	0.000996	CcSEcCtD
Dapagliflozin—Constipation—Epirubicin—stomach cancer	0.000103	0.000987	CcSEcCtD
Dapagliflozin—Nausea—Capecitabine—stomach cancer	0.000103	0.000984	CcSEcCtD
Dapagliflozin—Urticaria—Methotrexate—stomach cancer	0.000102	0.000979	CcSEcCtD
Dapagliflozin—Body temperature increased—Methotrexate—stomach cancer	0.000102	0.000975	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Doxorubicin—stomach cancer	9.6e-05	0.000922	CcSEcCtD
Dapagliflozin—Urticaria—Epirubicin—stomach cancer	9.55e-05	0.000917	CcSEcCtD
Dapagliflozin—Constipation—Doxorubicin—stomach cancer	9.51e-05	0.000913	CcSEcCtD
Dapagliflozin—Body temperature increased—Epirubicin—stomach cancer	9.5e-05	0.000912	CcSEcCtD
Dapagliflozin—Hypersensitivity—Methotrexate—stomach cancer	9.47e-05	0.000908	CcSEcCtD
Dapagliflozin—Hypersensitivity—Epirubicin—stomach cancer	8.86e-05	0.00085	CcSEcCtD
Dapagliflozin—Urticaria—Doxorubicin—stomach cancer	8.84e-05	0.000848	CcSEcCtD
Dapagliflozin—Body temperature increased—Doxorubicin—stomach cancer	8.79e-05	0.000844	CcSEcCtD
Dapagliflozin—Dizziness—Methotrexate—stomach cancer	8.5e-05	0.000815	CcSEcCtD
Dapagliflozin—Hypersensitivity—Doxorubicin—stomach cancer	8.2e-05	0.000787	CcSEcCtD
Dapagliflozin—Rash—Methotrexate—stomach cancer	8.1e-05	0.000777	CcSEcCtD
Dapagliflozin—Dermatitis—Methotrexate—stomach cancer	8.09e-05	0.000777	CcSEcCtD
Dapagliflozin—Headache—Methotrexate—stomach cancer	8.05e-05	0.000772	CcSEcCtD
Dapagliflozin—Dizziness—Epirubicin—stomach cancer	7.95e-05	0.000763	CcSEcCtD
Dapagliflozin—Nausea—Methotrexate—stomach cancer	7.63e-05	0.000732	CcSEcCtD
Dapagliflozin—Rash—Epirubicin—stomach cancer	7.58e-05	0.000727	CcSEcCtD
Dapagliflozin—Dermatitis—Epirubicin—stomach cancer	7.57e-05	0.000727	CcSEcCtD
Dapagliflozin—Headache—Epirubicin—stomach cancer	7.53e-05	0.000723	CcSEcCtD
Dapagliflozin—Dizziness—Doxorubicin—stomach cancer	7.36e-05	0.000706	CcSEcCtD
Dapagliflozin—Nausea—Epirubicin—stomach cancer	7.14e-05	0.000685	CcSEcCtD
Dapagliflozin—Rash—Doxorubicin—stomach cancer	7.01e-05	0.000673	CcSEcCtD
Dapagliflozin—Dermatitis—Doxorubicin—stomach cancer	7.01e-05	0.000672	CcSEcCtD
Dapagliflozin—Headache—Doxorubicin—stomach cancer	6.97e-05	0.000669	CcSEcCtD
Dapagliflozin—Nausea—Doxorubicin—stomach cancer	6.61e-05	0.000634	CcSEcCtD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	1.13e-05	0.000108	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PDHA1—stomach cancer	1.13e-05	0.000107	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—ECHS1—stomach cancer	1.13e-05	0.000107	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—GSTP1—stomach cancer	1.12e-05	0.000107	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—MTHFR—stomach cancer	1.12e-05	0.000107	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PLIN2—stomach cancer	1.11e-05	0.000106	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—HMOX1—stomach cancer	1.11e-05	0.000106	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CA2—stomach cancer	1.08e-05	0.000104	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.08e-05	0.000103	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—HMOX1—stomach cancer	1.08e-05	0.000103	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.08e-05	0.000103	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PGLS—stomach cancer	1.08e-05	0.000103	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—BLVRB—stomach cancer	1.08e-05	0.000103	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—ALOX5—stomach cancer	1.07e-05	0.000102	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	1.07e-05	0.000102	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PDHA1—stomach cancer	1.06e-05	0.000101	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—ECHS1—stomach cancer	1.06e-05	0.000101	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—FADS1—stomach cancer	1.06e-05	0.000101	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—TYMP—stomach cancer	1.06e-05	0.000101	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—NT5E—stomach cancer	1.06e-05	0.000101	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PGAM1—stomach cancer	1.06e-05	0.000101	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PDHA1—stomach cancer	1.05e-05	0.0001	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—ECHS1—stomach cancer	1.05e-05	0.0001	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—DPYD—stomach cancer	1.05e-05	0.0001	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—TYMS—stomach cancer	1.04e-05	9.95e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	1.04e-05	9.91e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—CD44—stomach cancer	1.04e-05	9.89e-05	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—CAV1—stomach cancer	1.03e-05	9.87e-05	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—APOA1—stomach cancer	1.03e-05	9.85e-05	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—GSTM1—stomach cancer	1.03e-05	9.84e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PPAP2A—stomach cancer	1.03e-05	9.8e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	1.02e-05	9.7e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	1.02e-05	9.7e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PLCE1—stomach cancer	1.01e-05	9.62e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—ALDH7A1—stomach cancer	1.01e-05	9.62e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—FADS1—stomach cancer	9.97e-06	9.52e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—TYMP—stomach cancer	9.97e-06	9.52e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—SREBF2—stomach cancer	9.91e-06	9.46e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—FADS1—stomach cancer	9.88e-06	9.44e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—TYMP—stomach cancer	9.88e-06	9.44e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—RORA—stomach cancer	9.79e-06	9.35e-05	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—ERCC2—stomach cancer	9.68e-06	9.25e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	9.67e-06	9.24e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—UMPS—stomach cancer	9.66e-06	9.23e-05	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—PIK3CA—stomach cancer	9.65e-06	9.22e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	9.59e-06	9.16e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	9.52e-06	9.09e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—SREBF2—stomach cancer	9.33e-06	8.92e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—GSTT1—stomach cancer	9.29e-06	8.87e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—SREBF2—stomach cancer	9.25e-06	8.84e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—RORA—stomach cancer	9.22e-06	8.81e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—CYP2A6—stomach cancer	9.18e-06	8.77e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—ALDOB—stomach cancer	9.17e-06	8.76e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CA1—stomach cancer	9.15e-06	8.74e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—NDUFA2—stomach cancer	9.15e-06	8.74e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—FBP1—stomach cancer	9.15e-06	8.74e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CKB—stomach cancer	9.15e-06	8.74e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—RORA—stomach cancer	9.14e-06	8.73e-05	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—MTHFR—stomach cancer	9.1e-06	8.69e-05	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—PPARG—stomach cancer	9.08e-06	8.68e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PDHA1—stomach cancer	8.98e-06	8.58e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—ECHS1—stomach cancer	8.98e-06	8.58e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—AKR1C3—stomach cancer	8.93e-06	8.53e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	8.81e-06	8.42e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PPP2R1A—stomach cancer	8.81e-06	8.41e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—ENO1—stomach cancer	8.7e-06	8.31e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—ALDOB—stomach cancer	8.64e-06	8.25e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—GSTP1—stomach cancer	8.64e-06	8.25e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PLIN2—stomach cancer	8.6e-06	8.21e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—ALDOB—stomach cancer	8.57e-06	8.18e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—ALB—stomach cancer	8.56e-06	8.18e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—ALOX5—stomach cancer	8.53e-06	8.14e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	8.52e-06	8.14e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—HMOX1—stomach cancer	8.52e-06	8.14e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—FADS1—stomach cancer	8.44e-06	8.07e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—TYMP—stomach cancer	8.44e-06	8.07e-05	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—CAV1—stomach cancer	8.4e-06	8.02e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—DPYD—stomach cancer	8.39e-06	8.01e-05	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—APOA1—stomach cancer	8.38e-06	8e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CA2—stomach cancer	8.37e-06	7.99e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—APOA1—stomach cancer	8.2e-06	7.84e-05	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—ALB—stomach cancer	8.17e-06	7.8e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—NT5E—stomach cancer	8.15e-06	7.79e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PGAM1—stomach cancer	8.15e-06	7.79e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	8.08e-06	7.72e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	8.06e-06	7.7e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—ALOX5—stomach cancer	8.03e-06	7.67e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—TYMS—stomach cancer	8.03e-06	7.67e-05	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	8.02e-06	7.66e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—ALOX5—stomach cancer	7.97e-06	7.61e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—GSTM1—stomach cancer	7.94e-06	7.58e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—SREBF2—stomach cancer	7.91e-06	7.55e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—DPYD—stomach cancer	7.9e-06	7.55e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—DPYD—stomach cancer	7.84e-06	7.48e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—RORA—stomach cancer	7.81e-06	7.46e-05	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—NOS3—stomach cancer	7.81e-06	7.46e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—ALDH7A1—stomach cancer	7.78e-06	7.43e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PLCE1—stomach cancer	7.78e-06	7.43e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—CD44—stomach cancer	7.72e-06	7.37e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	7.49e-06	7.15e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—ERCC2—stomach cancer	7.46e-06	7.13e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—UMPS—stomach cancer	7.46e-06	7.12e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—GSTT1—stomach cancer	7.42e-06	7.08e-05	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—PPARG—stomach cancer	7.38e-06	7.05e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—CYP2A6—stomach cancer	7.33e-06	7e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—ALDOB—stomach cancer	7.32e-06	6.99e-05	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—PTGS2—stomach cancer	7.15e-06	6.82e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—AKR1C3—stomach cancer	7.13e-06	6.81e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	7.1e-06	6.78e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—MTHFR—stomach cancer	7.02e-06	6.7e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—GSTT1—stomach cancer	6.99e-06	6.68e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—ENO1—stomach cancer	6.95e-06	6.64e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PDHA1—stomach cancer	6.93e-06	6.62e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—ECHS1—stomach cancer	6.93e-06	6.62e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—GSTT1—stomach cancer	6.93e-06	6.62e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—CYP2A6—stomach cancer	6.91e-06	6.6e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	6.9e-06	6.59e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	6.89e-06	6.58e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—CYP2A6—stomach cancer	6.85e-06	6.54e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—ALOX5—stomach cancer	6.81e-06	6.5e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—AKR1C3—stomach cancer	6.72e-06	6.42e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—DPYD—stomach cancer	6.7e-06	6.4e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—AKR1C3—stomach cancer	6.66e-06	6.36e-05	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—ALB—stomach cancer	6.64e-06	6.34e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PPP2R1A—stomach cancer	6.56e-06	6.27e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—ENO1—stomach cancer	6.55e-06	6.26e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—FADS1—stomach cancer	6.52e-06	6.22e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—TYMP—stomach cancer	6.52e-06	6.22e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	6.5e-06	6.21e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—ENO1—stomach cancer	6.49e-06	6.2e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—CAV1—stomach cancer	6.47e-06	6.18e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—APOA1—stomach cancer	6.46e-06	6.17e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—GSTP1—stomach cancer	6.44e-06	6.15e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	6.39e-06	6.1e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—HMOX1—stomach cancer	6.35e-06	6.06e-05	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—NOS3—stomach cancer	6.35e-06	6.06e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—CD44—stomach cancer	6.16e-06	5.89e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—SREBF2—stomach cancer	6.1e-06	5.83e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	6.07e-06	5.8e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—RORA—stomach cancer	6.03e-06	5.76e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—TYMS—stomach cancer	5.98e-06	5.72e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—GSTT1—stomach cancer	5.92e-06	5.66e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—GSTM1—stomach cancer	5.92e-06	5.65e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CYP2A6—stomach cancer	5.85e-06	5.59e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—CD44—stomach cancer	5.81e-06	5.55e-05	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—PTGS2—stomach cancer	5.81e-06	5.55e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—CD44—stomach cancer	5.76e-06	5.5e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—AKR1C3—stomach cancer	5.69e-06	5.44e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PPARG—stomach cancer	5.69e-06	5.43e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—ALDOB—stomach cancer	5.65e-06	5.4e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	5.59e-06	5.34e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—ERCC2—stomach cancer	5.56e-06	5.31e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—ENO1—stomach cancer	5.55e-06	5.3e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	5.46e-06	5.21e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—ALOX5—stomach cancer	5.25e-06	5.02e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PPP2R1A—stomach cancer	5.24e-06	5.01e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—MTHFR—stomach cancer	5.23e-06	4.99e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—DPYD—stomach cancer	5.17e-06	4.94e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—GSTP1—stomach cancer	5.14e-06	4.91e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—ALB—stomach cancer	5.12e-06	4.89e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—HMOX1—stomach cancer	5.07e-06	4.84e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PPP2R1A—stomach cancer	4.94e-06	4.72e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CD44—stomach cancer	4.92e-06	4.7e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PPP2R1A—stomach cancer	4.9e-06	4.68e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—NOS3—stomach cancer	4.89e-06	4.67e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—GSTP1—stomach cancer	4.84e-06	4.63e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—CAV1—stomach cancer	4.82e-06	4.61e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—APOA1—stomach cancer	4.81e-06	4.6e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—GSTP1—stomach cancer	4.8e-06	4.59e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—TYMS—stomach cancer	4.78e-06	4.57e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—HMOX1—stomach cancer	4.78e-06	4.56e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	4.77e-06	4.56e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—HMOX1—stomach cancer	4.74e-06	4.52e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—GSTM1—stomach cancer	4.72e-06	4.51e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	4.61e-06	4.4e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GSTT1—stomach cancer	4.57e-06	4.36e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CYP2A6—stomach cancer	4.52e-06	4.31e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—TYMS—stomach cancer	4.5e-06	4.3e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PTGS2—stomach cancer	4.48e-06	4.28e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—TYMS—stomach cancer	4.47e-06	4.26e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—GSTM1—stomach cancer	4.45e-06	4.25e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—ERCC2—stomach cancer	4.44e-06	4.24e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—GSTM1—stomach cancer	4.41e-06	4.22e-05	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—PIK3CA—stomach cancer	4.4e-06	4.2e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—AKR1C3—stomach cancer	4.39e-06	4.2e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—ENO1—stomach cancer	4.28e-06	4.09e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PPARG—stomach cancer	4.24e-06	4.05e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—ERCC2—stomach cancer	4.19e-06	4e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PPP2R1A—stomach cancer	4.18e-06	4e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—MTHFR—stomach cancer	4.18e-06	3.99e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—ERCC2—stomach cancer	4.15e-06	3.96e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—GSTP1—stomach cancer	4.1e-06	3.92e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—HMOX1—stomach cancer	4.05e-06	3.87e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—MTHFR—stomach cancer	3.93e-06	3.76e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—MTHFR—stomach cancer	3.9e-06	3.73e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—CAV1—stomach cancer	3.85e-06	3.68e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—APOA1—stomach cancer	3.84e-06	3.67e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—TYMS—stomach cancer	3.82e-06	3.64e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—ALB—stomach cancer	3.81e-06	3.64e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CD44—stomach cancer	3.8e-06	3.63e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—GSTM1—stomach cancer	3.77e-06	3.6e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—NOS3—stomach cancer	3.65e-06	3.48e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—CAV1—stomach cancer	3.63e-06	3.47e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—APOA1—stomach cancer	3.62e-06	3.46e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—CAV1—stomach cancer	3.6e-06	3.44e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—APOA1—stomach cancer	3.59e-06	3.43e-05	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—PIK3CA—stomach cancer	3.57e-06	3.41e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—ERCC2—stomach cancer	3.55e-06	3.39e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.44e-06	3.28e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PPARG—stomach cancer	3.39e-06	3.23e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PTGS2—stomach cancer	3.33e-06	3.19e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—MTHFR—stomach cancer	3.33e-06	3.18e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PPP2R1A—stomach cancer	3.23e-06	3.08e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PPARG—stomach cancer	3.19e-06	3.05e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GSTP1—stomach cancer	3.17e-06	3.03e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PPARG—stomach cancer	3.16e-06	3.02e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—HMOX1—stomach cancer	3.12e-06	2.98e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CAV1—stomach cancer	3.07e-06	2.94e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—APOA1—stomach cancer	3.07e-06	2.93e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—ALB—stomach cancer	3.04e-06	2.91e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—TYMS—stomach cancer	2.94e-06	2.81e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.94e-06	2.81e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—NOS3—stomach cancer	2.91e-06	2.78e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GSTM1—stomach cancer	2.91e-06	2.78e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—ALB—stomach cancer	2.87e-06	2.74e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—ALB—stomach cancer	2.84e-06	2.72e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PIK3CA—stomach cancer	2.75e-06	2.63e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—NOS3—stomach cancer	2.74e-06	2.62e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—ERCC2—stomach cancer	2.74e-06	2.61e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—NOS3—stomach cancer	2.72e-06	2.6e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PPARG—stomach cancer	2.7e-06	2.58e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PTGS2—stomach cancer	2.66e-06	2.54e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—MTHFR—stomach cancer	2.57e-06	2.46e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PTGS2—stomach cancer	2.51e-06	2.4e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PTGS2—stomach cancer	2.49e-06	2.38e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—ALB—stomach cancer	2.43e-06	2.32e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CAV1—stomach cancer	2.37e-06	2.27e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—APOA1—stomach cancer	2.37e-06	2.26e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—NOS3—stomach cancer	2.32e-06	2.22e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PTGS2—stomach cancer	2.13e-06	2.03e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PPARG—stomach cancer	2.09e-06	1.99e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PIK3CA—stomach cancer	2.05e-06	1.96e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—ALB—stomach cancer	1.88e-06	1.79e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—NOS3—stomach cancer	1.79e-06	1.71e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PTGS2—stomach cancer	1.64e-06	1.57e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PIK3CA—stomach cancer	1.64e-06	1.57e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PIK3CA—stomach cancer	1.54e-06	1.47e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PIK3CA—stomach cancer	1.53e-06	1.46e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PIK3CA—stomach cancer	1.31e-06	1.25e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PIK3CA—stomach cancer	1.01e-06	9.64e-06	CbGpPWpGaD
